日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response

建立患者来源的琥珀酸脱氢酶缺陷型胃肠道间质瘤模型以预测治疗反应

Mayra Yebra #, Shruti Bhargava #, Avi Kumar, Adam M Burgoyne, Chih-Min Tang, Hyunho Yoon, Sudeep Banerjee, Joseph Aguilera, Thekla Cordes, Vipul Sheth, Sangkyu Noh, Rowan Ustoy, Sam Li, Sunil J Advani, Christopher L Corless, Michael C Heinrich, Razelle Kurzrock, Scott M Lippman, Paul T Fanta, Olivie

Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation

PI3KCA、GNAS 和 PTEN 突变对伴有 MYOD1 L122R 突变的梭形细胞横纹肌肉瘤的功能影响和靶向性

Florence Choo, Igor Odintsov, Kevin Nusser, Katelyn S Nicholson, Lara Davis, Christopher L Corless, Linda Stork, Romel Somwar, Marc Ladanyi, Jessica L Davis, Monika A Davare

Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval

KIT 酪氨酸激酶活性抑制:首次获批二十年后

Lillian R Klug, Christopher L Corless, Michael C Heinrich

Mechanisms of targeted therapy resistance in a pediatric glioma driven by ETV6-NTRK3 fusion

ETV6-NTRK3 融合导致儿童胶质瘤靶向治疗耐药的机制

Clare Keddy, Tanaya Neff, Jianya Huan, Joshua P Nickerson, Catherine Z Beach, Yassmine Akkari, Jianling Ji, Stephen Moore, Kellie J Nazemi, Christopher L Corless, Carol Beadling, Randy Woltjer, Yoon-Jae Cho, Matthew D Wood, Monika A Davare

Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)

细胞周期基因的基因组畸变可预测 KIT 突变型胃肠道间质瘤 (GIST) 的进展

Michael C Heinrich #, Janice Patterson #, Carol Beadling, Yuexiang Wang, Maria Debiec-Rychter, Barbara Dewaele, Christopher L Corless, Anette Duensing, Chandrajit P Raut, Brian Rubin, Tamas Ordog, Matt van de Rijn, Jerry Call, Thomas Mühlenberg, Jonathan A Fletcher #, Sebastian Bauer #1

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors

“野生型”胃肠道间质瘤中 FGFR1 和 NTRK3 可操作改变

Eileen Shi, Juliann Chmielecki, Chih-Min Tang, Kai Wang, Michael C Heinrich, Guhyun Kang, Christopher L Corless, David Hong, Katherine E Fero, James D Murphy, Paul T Fanta, Siraj M Ali, Martina De Siena, Adam M Burgoyne, Sujana Movva, Lisa Madlensky, Gregory M Heestand, Jonathan C Trent, Razelle Kur

Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance

KIT 和 FGFR3 之间的串扰促进胃肠道基质肿瘤细胞生长和耐药性

Nathalie Javidi-Sharifi, Elie Traer, Jacqueline Martinez, Anu Gupta, Takehiro Taguchi, Jennifer Dunlap, Michael C Heinrich, Christopher L Corless, Brian P Rubin, Brian J Druker, Jeffrey W Tyner

Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data

评估靶向扩增子的新一代测序数据中的拷贝数变异

Catherine Grasso, Timothy Butler, Katherine Rhodes, Michael Quist, Tanaya L Neff, Stephen Moore, Scott A Tomlins, Erica Reinig, Carol Beadling, Mark Andersen, Christopher L Corless

Genetic profiling to determine risk of relapse-free survival in high-risk localized prostate cancer

通过基因分析确定高风险局限性前列腺癌的无复发生存风险

Christine M Barnett, Michael C Heinrich, Jeong Lim, Dylan Nelson, Carol Beadling, Andrea Warrick, Tanaya Neff, Celestia S Higano, Mark Garzotto, David Qian, Christopher L Corless, George V Thomas, Tomasz M Beer

Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)

四重野生型GIST(KIT/PDGFRA/SDH/RAS通路野生型GIST)的整合基因组学研究

Margherita Nannini, Annalisa Astolfi, Milena Urbini, Valentina Indio, Donatella Santini, Michael C Heinrich, Christopher L Corless, Claudio Ceccarelli, Maristella Saponara, Anna Mandrioli, Cristian Lolli, Giorgio Ercolani, Giovanni Brandi, Guido Biasco, Maria A Pantaleo